Hadlima
Search results
Scope
Date
~
-
Bio & PharmaSamsung Bioepis to supply Hadlima to US government
South Korea’s Samsung Bioepis and the US-based Organon, the local partner company of Samsung group's biopharmaceutical research and developmen...
Feb 21, 2024 (Gmt+09:00)
-
Bio & PharmaSamsung Bioepis enters US market for biosimilars of Humira
South Korea's biopharmaceutical company Samsung Bioepis, which was expected to struggle on the US market for biosimilars of Humira, the world's top-...
Jul 14, 2023 (Gmt+09:00)
1
Latest News
- 1 Hamilton Lane invests in IMM infrastructure fund
- 2 Seoul’s prime office transactions rise 6% in Q1 despite weak sentiment
- 3 S.Korea's crypto market doubles to $77.5 bn, with 20% of population trading
- 4 KIC discusses post-US tariff infrastructure strategy with pension funds
- 5 LG poised to extend OLED TV market lead into 2025
